Literature DB >> 12468524

Correction of partial-volume effect for PET striatal imaging: fast implementation and study of robustness.

Vincent Frouin1, Claude Comtat, Anthonin Reilhac, Marie-Claude Grégoire.   

Abstract

UNLABELLED: PET imaging of D(2) receptors or (18)F-L-dopa metabolism are reference protocols to follow and study neurodegenerative diseases, but the accuracy of striatal PET imaging is limited by the partial-volume effect (PVE). For such studies, the geometric transfer matrix (GTM) method has been proposed to correct the regional mean values for PVE and is now widely used.
METHODS: The GTM method models the geometric interactions induced by the PET system between the anatomic regions in which PVE correction is performed. This implies estimation of the corresponding regional spread function (RSF). The literature describes 2 implementations for the RSF calculation; they differ in the way the point spread function (PSF) of the imaging system is modeled, but no comparison or discussion has been given. The first and reference implementation uses an accurate intrinsic detector PSF that is applied in the sinogram space. The second uses a global PSF that is applied in the image space. In this work, we compared the 2 GTM implementations for 3-dimensional (3D) PET striatal imaging using Monte Carlo simulations and a phantom study. We studied the robustness of the GTM correction with respect to residual registration errors between PET and anatomy and with respect to residual segmentation errors.
RESULTS: Despite the differences in RSF calculation and computation cost between the 2 implementations, similar recovery results were obtained (between 95% and 100%). The study of robustness of the GTM correction yielded 2 results. A realistic residual misregistration between the anatomic and PET images did not modify the algorithm accuracy but decreased its precision. Conversely, a realistic residual missegmentation of the anatomic regions submitted to GTM correction decreased the correction accuracy.
CONCLUSION: A simple but efficient implementation in the image space of the GTM method yields accurate PVE correction in striatal regions in studies with 3D PET and enables clinical use. The method is less sensitive to residual misregistration errors between PET and anatomy than to residual missegmentation of the anatomy. Special care should be taken with segmentation of the regions to correct for PVE.

Entities:  

Mesh:

Year:  2002        PMID: 12468524

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  38 in total

1.  An MR image-guided, voxel-based partial volume correction method for PET images.

Authors:  Hesheng Wang; Baowei Fei
Journal:  Med Phys       Date:  2012-01       Impact factor: 4.071

2.  Anatomical-based partial volume correction for low-dose dedicated cardiac SPECT/CT.

Authors:  Hui Liu; Chung Chan; Yariv Grobshtein; Tianyu Ma; Yaqiang Liu; Shi Wang; Mitchel R Stacy; Albert J Sinusas; Chi Liu
Journal:  Phys Med Biol       Date:  2015-08-21       Impact factor: 3.609

3.  Ventricular muscarinic receptor remodeling in patients with and without primary ventricular fibrillation. An imaging study.

Authors:  Alejandro N Mazzadi; Julien Pineau; Nicolas Costes; Didier Le Bars; Fréderic Bonnefoi; Raphaël Porcher; Pierre Croisille; Philippe Chevalier
Journal:  J Nucl Cardiol       Date:  2012-05-17       Impact factor: 5.952

4.  Does subthalamic nucleus stimulation affect the frontal limbic areas? A single-photon emission computed tomography study using a manual anatomical segmentation method.

Authors:  C Haegelen; M Verin; B Aubert Broche; F Prigent; P Jannin; B Gibaud; X Morandi
Journal:  Surg Radiol Anat       Date:  2005-09-14       Impact factor: 1.246

5.  Partial-volume effect correction in positron emission tomography brain scan image using super-resolution image reconstruction.

Authors:  T Meechai; S Tepmongkol; C Pluempitiwiriyawej
Journal:  Br J Radiol       Date:  2014-12-10       Impact factor: 3.039

6.  Direct (17)O MRI with partial volume correction: first experiences in a glioblastoma patient.

Authors:  Stefan H Hoffmann; Alexander Radbruch; Michael Bock; Wolfhard Semmler; Armin M Nagel
Journal:  MAGMA       Date:  2014-04-01       Impact factor: 2.310

7.  Autosomal Dominantly Inherited Alzheimer Disease: Analysis of genetic subgroups by Machine Learning.

Authors:  Diego Castillo-Barnes; Li Su; Javier Ramírez; Diego Salas-Gonzalez; Francisco J Martinez-Murcia; Ignacio A Illan; Fermin Segovia; Andres Ortiz; Carlos Cruchaga; Martin R Farlow; Chengjie Xiong; Neil R Graff-Radford; Peter R Schofield; Colin L Masters; Stephen Salloway; Mathias Jucker; Hiroshi Mori; Johannes Levin; Juan M Gorriz
Journal:  Inf Fusion       Date:  2020-01-07       Impact factor: 12.975

8.  Partial volume correction in quantitative amyloid imaging.

Authors:  Yi Su; Tyler M Blazey; Abraham Z Snyder; Marcus E Raichle; Daniel S Marcus; Beau M Ances; Randall J Bateman; Nigel J Cairns; Patricia Aldea; Lisa Cash; Jon J Christensen; Karl Friedrichsen; Russ C Hornbeck; Angela M Farrar; Christopher J Owen; Richard Mayeux; Adam M Brickman; William Klunk; Julie C Price; Paul M Thompson; Bernadino Ghetti; Andrew J Saykin; Reisa A Sperling; Keith A Johnson; Peter R Schofield; Virginia Buckles; John C Morris; Tammie L S Benzinger
Journal:  Neuroimage       Date:  2014-12-05       Impact factor: 6.556

9.  SPECT and PET analysis of subthalamic stimulation in Parkinson's disease: analysis using a manual segmentation.

Authors:  Claire Haegelen; Daniel García-Lorenzo; Florence Le Jeune; Julie Péron; Bernard Gibaud; Laurent Riffaud; Gilles Brassier; Christian Barillot; Marc Vérin; Xavier Morandi
Journal:  J Neurol       Date:  2009-09-23       Impact factor: 4.849

10.  Partial volume correction strategies for quantitative FDG PET in oncology.

Authors:  Nikie J Hoetjes; Floris H P van Velden; Otto S Hoekstra; Corneline J Hoekstra; Nanda C Krak; Adriaan A Lammertsma; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-27       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.